de Wolf F - Search Results

1

Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine.

de Gans J, Lange JM, Derix MM, de Wolf F, Eeftinck Schattenkerk JK, Danner SA, Ongerboer de Visser BW, Cload P, Goudsmit J. de Gans J, et al. Among authors: de wolf f. AIDS. 1988 Feb;2(1):37-40. doi: 10.1097/00002030-198802000-00006. AIDS. 1988. PMID: 3128994

2

Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men.

Mulder JW, Frissen PH, Krijnen P, Endert E, de Wolf F, Goudsmit J, Masterson JG, Lange JM. Mulder JW, et al. Among authors: de wolf f. J Infect Dis. 1992 Mar;165(3):413-8. doi: 10.1093/infdis/165.3.413. J Infect Dis. 1992. PMID: 1347053

3

Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype.

Schellekens PT, Tersmette M, Roos MT, Keet RP, de Wolf F, Coutinho RA, Miedema F. Schellekens PT, et al. Among authors: de wolf f. AIDS. 1992 Jul;6(7):665-9. doi: 10.1097/00002030-199207000-00008. AIDS. 1992. PMID: 1354447

4

Concordance of human immunodeficiency virus detection by polymerase chain reaction and by serologic assays in a Dutch cohort of seronegative homosexual men.

Bruisten SM, Koppelman MH, Dekker JT, Bakker M, de Goede RE, Roos MT, de Wolf F, Coutinho RA, Goudsmit J, Huisman HG. Bruisten SM, et al. Among authors: de goede re, de wolf f. J Infect Dis. 1992 Sep;166(3):620-2. doi: 10.1093/infdis/166.3.620. J Infect Dis. 1992. PMID: 1500745

5

Markers for progression to AIDS during natural infection and antiviral therapy.

Goudsmit J, de Wolf F. Goudsmit J, et al. Among authors: de wolf f. Pathol Biol (Paris). 1992 Nov;39(9):873. Pathol Biol (Paris). 1992. PMID: 1538916 No abstract available.

6

Differences in clinical course in zidovudine-treated asymptomatic HIV-infected men associated with T-cell function at intake.

Gruters RA, Terpstra FG, Lange JM, Roos MT, Harkema T, Mulder JW, De Wolf F, Schellekens PT, Miedema F. Gruters RA, et al. Among authors: de wolf f. AIDS. 1991 Jan;5(1):43-7. doi: 10.1097/00002030-199101000-00006. AIDS. 1991. PMID: 1676272

7

Serologic and immunologic markers in the course of HIV-1 infection.

de Wolf F, Lange JM. de Wolf F, et al. Clin Dermatol. 1991 Jan-Mar;9(1):1-11. doi: 10.1016/0738-081x(91)90110-7. Clin Dermatol. 1991. PMID: 1682023 Review. No abstract available.

8

Characterization of human antibody-binding sites on the external envelope of human immunodeficiency virus type 2.

de Wolf F, Meloen RH, Bakker M, Barin F, Goudsmit J. de Wolf F, et al. J Gen Virol. 1991 Jun;72 ( Pt 6):1261-7. doi: 10.1099/0022-1317-72-6-1261. J Gen Virol. 1991. PMID: 1710645

9

Immunological and virological markers in individuals progressing from seroconversion to AIDS.

Gruters RA, Terpstra FG, De Goede RE, Mulder JW, De Wolf F, Schellekens PT, Van Lier RA, Tersmette M, Miedema F. Gruters RA, et al. Among authors: de goede re, de wolf f. AIDS. 1991 Jul;5(7):837-44. doi: 10.1097/00002030-199107000-00007. AIDS. 1991. PMID: 1892588

10

Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.

Reiss P, de Wolf F, Kuiken CL, de Ronde A, Dekker J, Boucher CA, Debouck C, Lange JM, Goudsmit J. Reiss P, et al. Among authors: de ronde a, de wolf f. J Acquir Immune Defic Syndr (1988). 1991;4(2):165-72. J Acquir Immune Defic Syndr (1988). 1991. PMID: 1898969

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters